Skip to main content

About me

I am a registered patent attorney with the U.S. Patent and Trademark Office (USPTO) and am admitted to practice law in the state of California. I specialize in advising corporations and universities in obtaining patent protection for their biotech, chemical, pharmaceutical, and medical device inventions. Having over ten years of experience in preparing and prosecuting U.S. and foreign patent applications, I regularly advise clients on their patent portfolios and patent strategies. In addition, I also counsel clients on various business and licensing transactions by conducting intellectual property due diligence investigations, as well as by authoring opinion letters regarding patent invalidity and non-infringement.

I received my Bachelor of Science degree in Chemistry from Rowan University, and my Ph.D. in synthetic organic chemistry from the University of Delaware. After doing post-doctoral studies in synthetic organic and medicinal chemistry at the University of South Carolina and The Upjohn Company, I worked as a medicinal chemist at several San Diego biotech companies before going into law. I received my J.D. from the University of San Diego School Of Law in May of 2002. While in law school, I worked as a patent agent at Isis Pharmaceuticals and Heller Ehrman LLP. After graduating from law school, I worked as Corporate Counsel at Pfizer Inc., as an Associate at Townsend, Townsend and Crew LLP, and was Of Counsel at DLA Piper LLP before joining Tech Law LLP.

In addition to my admission to the USPTO and California bars, I’m also a long-standing member of the American Chemical Society, American Bar Association, American Intellectual Property Law Association, San Diego Intellectual Property Law Association, and the Licensing Executives Society.

I can be reached by e-mail at, or by telephone at 619.213.7483.


Photos and videos

330895 1349230750

330895 1349230715

Practice areas


  1. Patent Application: 34%
    16 years
  2. Patent Infringement: 33%
    16 years
  3. Intellectual Property: 33%
    16 years



Free consultation (30 minutes)

Payment types:

Cash, Check, Credit card

Attorney endorsements

3 total 

Are you an attorney? Endorse this lawyer

  • Christine Ann Kingston

    I endorse this lawyer. Attorney Robinson is smart and applies that intelligence to zealously represent his clients. I highly recommend his work for patent applications requiring his technical expertise.


    Christine Kingston Chapter 13 bankruptcy Attorney
    Relationship: Fellow lawyer in community

  • Christian K. Lassen II

    Top-notch attorney. Highly respected in the legal community.


    Christian Lassen Wrongful death Attorney
    Relationship: Fellow lawyer in community

Contact info

TechLaw LLP

6265 Greenwich Dr.
Suite 201
San Diego, CA, 92122


We have not found any instances of professional misconduct for this lawyer.
Avvo contributions
Legal answers
Award nameGrantorDate granted
Clients Choice - Patent ApplicationAvvo2013
Top Contributor - Patent ApplicationAvvo2013
ACS Award for ExcellenceAmerican Chemical Society1981
Work experience
TitleCompany nameDuration
Of CounselTechLaw LLP2012 - Present
Of CounselDLA Piper US, LLP2009 - 2012
AssociateTownsend, Townsend & Crew, LLP2006 - 2008
Corporate CounselPfizer, Inc.2003 - 2006
Association namePosition nameDuration
American Bar AssociationAttorney2003 - Present
American Intellectual Property Law AssociationAttorney2003 - Present
San Diego Intellectual Property Law AssociationAttorney2000 - Present
Legal cases
Case nameOutcome
U.S. Patent No. 8,481,501Allowed
See all legal cases 
Publication nameTitleDate
www.chembiotechpatentlaw.comHas the Patent Examiner Established A Prima Facie Case For Obviousness?2013
www.chembiotechpatentlaw.comPart 2: Patent Term Adjustment – Request For Continued Examination (RCE)2013
www.chembiotechpatentlaw.com5 Considerations for the New America Invents Act2013
www.chembiotechpatentlaw.comWhy Do Patents Cost So Much?2013
www.chembiotechpatentlaw.comKiadis Pharma Receives U.S. Patent For AITR2013
www.chembiotechpatentlaw.comPatent Abuse Reduction Act of 2013 Introduced in U.S. Congress2013
www.chembiotechpatentlaw.comThe Patent Exhaustion Doctrine Does Not Extend To Self-Replicating Plant Seeds2013
www.chembiotechpatentlaw.comOfficial Seals Of Cites Are Not Eligible For Trademark Protection2013
www.chembiotechpatentlaw.comMedtronic Continues Tests On Heart Valve System While Patent Feud With Edwards Continues2013
www.chembiotechpatentlaw.comPatent Claim Terms Lacking A Consistent Explicit Definition In Their Specification Are Broadly Construed During Patent Reexamination2013
www.chembiotechpatentlaw.comBeing A Direct Or Contributory Patent Infringer Is Not Required To Seek Declaratory Relief2013
www.chembiotechpatentlaw.comPatent Claim Terms Are Construed Based On The Meaning Given In The Specification And Used During Patent Prosecution2013
www.chembiotechpatentlaw.comA Patent Application Must Be Filed As A Result Of A Restriction Requirement For The Double Patenting Safe Harbor Provisions Of 35 U.S.C. § 121 To Apply2013
www.chembiotechpatentlaw.comThe Best Mode Requirement Is Satisfied When The Specification Includes The Preferred Mode2013
www.chembiotechpatentlaw.comShould I Get A Patent Or Trade Secret Protection For My Invention?2013
www.chembiotechpatentlaw.comSecondary Considerations For Nonobviousness Must Be Commensurate With The Patent Claims2013
www.chembiotechpatentlaw.comExpert Testimony Can Substantiate The Meaning Of A Patent Claim Term2013
www.chembiotechpatentlaw.comA Finding Of Obviousness May Be Made When Prior Art References Set Forth Every Limitation Of The Claims And Provide Express Motivation To Combine Those Teachings2013
www.chembiotechpatentlaw.comThe SHIELD Act of 20132013
www.chembiotechpatentlaw.comHasbro Calls For Removal Of My Little Pony Online Game2013
www.chembiotechpatentlaw.comKraft Wins Appeals Court Ruling Against Cracker Barrel Restaurants2013
www.chembiotechpatentlaw.comPatent Claims May Not Be Obvious If There Are Factual Errors In The Analysis Of Prior Art2013
www.chembiotechpatentlaw.comChemical Obviousness: Is It Obvious To Substitute An Amide For An Ester Or Carboxylic Acid?2013
www.chembiotechpatentlaw.comInterference Proceedings Will Continue For Applications And Patents That Were Filed Before The Enactment Of The American Invents Act2013
www.chembiotechpatentlaw.comA Defendant’s Reliance Upon An Admission By Its Opponent During Patent Litigation Is Not An Objectively Baseless Reason To Award Attorneys’ Fees Under 35 U.S.C. § 2852013
www.chembiotechpatentlaw.comThe Federal Trade Commission (FTC) Issues Study Results Supporting Its Claim That Pay-For-Delay Deals Are Anti-Competitive2013
www.chembiotechpatentlaw.comPatenting Biotechnology and Methods of Medical Treatment2013
www.chembiotechpatentlaw.comIn A Means-Plus-Function Patent Claim, The Structure May Be Limited To A Single Disclosed Example2013
www.chembiotechpatentlaw.comThe Patent Law Treaties Implementation Act of 20122013
www.chembiotechpatentlaw.comTech Giants Take Advantage Of New Law To Avoid Court Battles Over Patent Claims2013
www.chembiotechpatentlaw.comInter Partes Reexaminations Filed Before The Enactment of The America Invents Act Does Not Allow The Use Of Subpoenas And Depositions In Matters Before A Patent Examiner2013
www.chembiotechpatentlaw.comAn Invention That Recognizes And Solves A Problem May Not Be Obvious Over A Broad Disclosure Of Prior Art2013
www.chembiotechpatentlaw.comNo Explanations Are Required For An Unintentional Delay In Paying Patent Maintenance Fees2013
www.chembiotechpatentlaw.comNaturally Occurring DNA Is A Product Of Nature And Not Eligible For Patenting2013
www.chembiotechpatentlaw.comPatent Claims Must Be Definite, Even If They Lead To The Formation Of The INTERNET2013
www.chembiotechpatentlaw.com2013 Sequester May Bring A Financial Crisis For The U.S. Patent & Trademark Office2013
www.chembiotechpatentlaw.comMethod Claims Do Not Save A Sold Patented Article From Patent Exhaustion2013
www.chembiotechpatentlaw.comFor A Contract To Be Unenforceable, The Contract Must Be Unconscionable At The Time Of Contracting2013
www.chembiotechpatentlaw.comArthrex Must Stop Selling Products In Violation Of Smith & Nephew’s Patent2013
www.chembiotechpatentlaw.comThe Meaning Of Patent Claim Terms2013
www.chembiotechpatentlaw.comAssignment Estoppel Cannot Be Used As A Basis For A Declaratory Judgment Action2013
www.chembiotechpatentlaw.comHow do I Start Using a New Trademark or Service Mark With My Business?2013
www.chembiotechpatentlaw.comIs Your Invention Novel?2013
www.chembiotechpatentlaw.comPatent Claims Using The Open-Ended Transitional Term “Comprising,” Read On Devices That Include Additional Features2013
www.chembiotechpatentlaw.comClaim Terms Are Ambiguous If They Are Given Different Meanings During Patent Prosecution2013
www.chembiotechpatentlaw.comUSPTO Steps to Filing: Step 3 – After Close of Prosecution2013
www.chembiotechpatentlaw.comProcter & Gamble Accuses Unilever of Patent Infringement2013
www.chembiotechpatentlaw.comUSPTO Steps to Filing: Step 1 – Filing/First Action2013
www.chembiotechpatentlaw.comApple Awarded More Than 60 Patents in the First Two Weeks of 20132013
www.chembiotechpatentlaw.comProsecution History Estoppel Prevents A Patent Owner From Recapturing Subject Matter Surrendered To Acquire A Patent2013
www.chembiotechpatentlaw.comDoes Your Chemical or Biotechnological Invention Satisfy the Requirement of Utility?2013
www.chembiotechpatentlaw.comA Reasonable Amount of Routine Experimentation Required to Practice a Claimed Invention Does Not Violate The Enablement Requirement2013
www.chembiotechpatentlaw.comGin Distillers Tee Up Trademark Litigation Over the Brand Names of Their Spirits2013
www.chembiotechpatentlaw.comThe Meaning Of Patent Claim Terms2013
www.chembiotechpatentlaw.comPatent Claims Must Be Adequately Supported By The Specification2013
www.chembiotechpatentlaw.comThe Shop Rights Doctrine Is A Judicially Created Defense to Patent Infringement2013
www.chembiotechpatentlaw.comDoes The Use Of A Drug During Clinical Trials Constitute A Public Use Under 35 USC 102(b)?2013
www.chembiotechpatentlaw.comThe Tariff Act Of 1930 Requires The Existence Of A Domestic Industry In The U.S.2013
www.chembiotechpatentlaw.comWhat to Do Now to Prepare-for-the AIA's First-Inventor-to-File System/2013
www.chembiotechpatentlaw.comIsn’t It Obvious?2013
www.chembiotechpatentlaw.comPatent Related Settlement Agreements Can Sometimes Violate Antitrust Laws2013
www.chembiotechpatentlaw.comTrue Religion Apparel Inc Sues 100 Defendants For Trademark Infringement2013
www.chembiotechpatentlaw.comWhat Happens if a Patent Owner Fails to Pay Maintenance Fees?2013
www.chembiotechpatentlaw.comKruse Technology Partnership v. Volkswagen AG2013
www.chembiotechpatentlaw.comFalse Statements In A Declaration To The USPTO May Invalidate A Patent For Inequitable Conduct2013
www.chembiotechpatentlaw.comGerman Court Restores Medtronic’s Right To Sell Heart Valve2013
www.chembiotechpatentlaw.comPatenting Your Invention and Making Money, is it Possible?2013
www.chembiotechpatentlaw.comProsecution History Estoppel: Arguments Made During Prosecution Of A Patent Application May Be Used To Limit The Meaning Of The Claims During Patent Litigation2013
www.chembiotechpatentlaw.comWhen The Patent Office Invalidates A Patent, It Is No Longer In Force And The District And Federal Courts Can No Longer Act2013
www.chembiotechpatentlaw.comChanges Under America Invents Act (AIA) Slated to Take Effect March 16, 20132013
www.chembiotechpatentlaw.comDo Patent Attorneys Do Pro Bono Work?2013
www.chembiotechpatentlaw.comA New Method That Uses An Obvious Composition May Not Be Obvious If Unexpected Results Can Be Shown2013
www.chembiotechpatentlaw.comKAHR Medical Ltd. Receives A U.S. Patent for KAHR-1012013
www.chembiotechpatentlaw.comIP Hall of Fame Academy Nominations2013
www.chembiotechpatentlaw.comSCOTUS Sides with Edwards against Medtronic in Heart Valve Patent Dispute2013
www.chembiotechpatentlaw.comEven A Known Means Plus Function Limitation Will Make A Patent Claim Indefinite If It Is Not Described In The Specification2013
www.chembiotechpatentlaw.comNew Prior Art May Be Used As Evidence To Overcome The Validity Of An Issued Patent2013
www.chembiotechpatentlaw.comAn Invalidating Public Use Of An Invention Need Not Be The Intended Or Patented Use2013
www.chembiotechpatentlaw.comThe Same Claim Term Can Have Different Constructions Depending Upon The Context Of How The Term Is Used2013
www.chembiotechpatentlaw.comUniversities, Research Institutes and Other Non-Practicing Entities, i.e. Patent Trolls, Do Not Have To Manufacture Their Patented Goods In The U.S. In Order To File A Patent Infringement Suit Under 19 U.S.C. § 13372013
www.chembiotechpatentlaw.comIs Chemical Obviousness Based Upon A Motivation To Select A Lead Compound To Modify?2013
www.chembiotechpatentlaw.comA Patent Applicant’s Response To A Restriction Requirement May Be Used To Interpret Patent Claim Terms Or As A Source Of Disclaimer2013
www.chembiotechpatentlaw.comWhy Inventors Decide Not To Patent Their Inventions2013
www.chembiotechpatentlaw.comInherent Anticipation Requires That A Prior Art Reference Must Necessarily Include The Unstated Patent Claim Limitation2013
www.chembiotechpatentlaw.comTechForward Scores 22 Million Plus Another 5 Million In The Bonus Round2013
www.chembiotechpatentlaw.comProtecting Semiconductor Chip Products2013
www.chembiotechpatentlaw.comPatent Protection In China2013
www.chembiotechpatentlaw.comCriticisms In A Patent Do Not Amount To A Clear Disavowal Of Claim Scope2013
www.chembiotechpatentlaw.comA Correct Patent Claim Construction Stays True To the Claim Language And Most Naturally Aligns Itself With the Description In the Specification2013
www.chembiotechpatentlaw.comDoes Collateral Estoppel Bar Patent Claims That Were Never Actually Litigated?2013
www.chembiotechpatentlaw.comPatent Claims Are Definite If They Inherently Provide Parameters Sufficient For A Skilled Artisan To Understand Their Boundaries2013
www.chembiotechpatentlaw.comTesla’s Trademark Battle in China2013
www.chembiotechpatentlaw.comPart II: The AIA Changes The Requirements For Novelty Under 35 U.S.C. § 102 – The One Year Grace Period2013
www.chembiotechpatentlaw.comThe Supreme Court Will Consider Pay For Delay Agreements Used To Resolve Patent Litigation2013
www.chembiotechpatentlaw.comThe Statutory Amendment Eliminating The Best Mode Requirement For Invalidating A Patent Was Not Given Retroactive Effect Under The American Invents Act2013
www.chembiotechpatentlaw.comMeans-Plus-Function Patent Claims May Be Indefinite If The Specification Doesn’t Tie Concrete Structures With The Claimed Function2013
www.chembiotechpatentlaw.comPrior Conception Of An Invention May Be Shown By Possession And Appreciation Of It’s Properties2013
www.chembiotechpatentlaw.comSupreme Court to Review Medtronic v. Boston2013
www.chembiotechpatentlaw.comWhat Countries Should I Select For Foreign Patent Protection?2013
www.chembiotechpatentlaw.comPatent Claims Must Be Understood When Read In Light Of The Specification2013
www.chembiotechpatentlaw.comA Patent Interference Proceeding Should Be Used To Determine Inventorship Instead Of Correcting Inventorship Under 35 U.S.C. §§ 116 or 2562013
www.chembiotechpatentlaw.comPatents for Humanity Awards2013
www.chembiotechpatentlaw.comUSPTO Offers Free Information to Assist Patent Applicants2013
www.chembiotechpatentlaw.comWritten Description, Enablement and The Budapest Treaty2013
www.chembiotechpatentlaw.comA Terminal Disclaimer Can’t Overcome An Obviousness-Type Double Patenting Rejection When The Inventors Assign Their Rights to Different Entities2013
www.chembiotechpatentlaw.comKB Home Sues FL Homeowners For Trademark Infringement Over Critical Website2013
www.chembiotechpatentlaw.comPart III: The AIA Changes The Requirements For Novelty Under 35 U.S.C. § 102 – Derivation2013
www.chembiotechpatentlaw.comA Patent Application That Describes A Genus May Not Have Sufficient Written Description To Claim A Particular Species2013
www.chembiotechpatentlaw.comShould Inventors Be More Patent-Minded?2013
www.chembiotechpatentlaw.comDo License Agreements Extend To Reissue Patents?2013
www.chembiotechpatentlaw.comThe USPTO Grants Patent to Regenerative Medicine Company Mesoblast Limited2013
www.chembiotechpatentlaw.comPart 1: Patent Term Adjustment – A Delays, B Delays and Overlap2013
www.chembiotechpatentlaw.comRecent US Patent Fee Increases2013
www.chembiotechpatentlaw.comUSPTO Steps to Filing: Step 5 – After Payment of The Issue Fee2013
www.chembiotechpatentlaw.comAn AIA Fact Pattern With No Solution2013
www.chembiotechpatentlaw.comA Patent May Not Be Enabling If It Discloses Only A Starting Point For Further Research In An Unpredictable And Poorly Understood Field2013
www.chembiotechpatentlaw.comUSPTO Steps to Filing: Step 4 – After Notice of Appeal2013
www.chembiotechpatentlaw.comIn Re Violation of Rule 502013
www.chembiotechpatentlaw.comA Patent Position Taken During Reexamination Cannot Be Changed On Appeal2013
www.chembiotechpatentlaw.comWhether Patent Claims Are Obvious Is Determined By The Standards Set Forth In KSR International2013
www.chembiotechpatentlaw.comNot Only Is The Patent False Marking Gravy Train Over, It Never Really Existed2013
www.chembiotechpatentlaw.comA Patent May Be Obvious If All Of The Claim Elements Are Found In The Prior Art And There Is A Motivation To Combine Them As In The Patented Invention2013
www.chembiotechpatentlaw.comHow Do I Start the Patent Process?2013
www.chembiotechpatentlaw.comClaim Construction Must Be Consistent With The Way The Patented Claims Are Written2013
www.chembiotechpatentlaw.comThe Preamble Of A Patent Claim May Limit An Invention2013
www.chembiotechpatentlaw.comThe AIA Keeps The Best Mode Requirement For Patentability But Not For Validity2013
www.chembiotechpatentlaw.comA Single Prior Art Reference Must Disclose Each And Every Limitation Of The Claimed Invention, Either Explicitly Or Inherently, To Be Novelty Destroying2013
www.chembiotechpatentlaw.comBusiness Method Patents2013
www.chembiotechpatentlaw.comWhat’s an Improvement Patent?2013
www.chembiotechpatentlaw.comRedHill Biopharma Receives U.S. Patent for Treatment of Crohn’s Disease2013
www.chembiotechpatentlaw.comStanding To Challenge A Patent Requires A Demonstration That A Substantial Risk Of Harm Will Occur2013
www.chembiotechpatentlaw.comPart IV: The AIA Changes The Requirements For Novelty Under 35 U.S.C. § 102 – Common Ownership2013
www.chembiotechpatentlaw.comChanging Patent Law Firms Midstream May Lead ToA Conflict Of Interest2013
www.chembiotechpatentlaw.comCollateral Estoppel Applies To Patent Claim Terms That Were Determinative To The Outcome Of A Prior Lawsuit Even If The Claims Contain Additional Terms That Were Not Previously Construed2013
www.chembiotechpatentlaw.comOnce An Aspect Of A Patent Claim Is Disavowed, It Is Not Possible To Recapture It During Patent Infringement Litigation2013
www.chembiotechpatentlaw.comPatent Claim Terms Must Be Consistently Defined In All Patent Infringement Proceedings2013
www.chembiotechpatentlaw.comThe Most Reliable Proof For Corroborating A Witness’s Testimony Is Documentary Or Physical Evidence That Was Made During The Same Time Period2013
www.chembiotechpatentlaw.comDey L.P., Dey, Inc. and Mylan, Inc. v. Sunovian Pharmaceuticals, Inc.2013
www.chembiotechpatentlaw.comGoogle Agrees to Limit Injunctions Sought Against Rivals2013
www.chembiotechpatentlaw.comThe First Sale Doctrine Applies To Copyrighted Works That Are Legally Made Abroad And Which Are Imported And Sold In The U.S.2013
www.chembiotechpatentlaw.comThe Number Of Patents For SmartPhone Technology Has Exploded2013
www.chembiotechpatentlaw.comUSPTO Steps To Filing: Step 2 – First Action/Final Rejection2013
www.chembiotechpatentlaw.comPart I: The AIA Changes The Requirements For Novelty Under 35 U.S.C. § 102 – The Filing Date2013
www.chembiotechpatentlaw.comThe Doctrine of Equivalents and Vitiation2012
www.chembiotechpatentlaw.comThe Doctrine of Claim Differentiation Does Not Change the Preamble Term Comprising2012
www.chembiotechpatentlaw.comRes Judicata and Claim Preclusion: File All Causes of Action in the First Lawsuit2012
www.chembiotechpatentlaw.comNon-Analogous Prior Art in the Determination of Obviousness2012
www.chembiotechpatentlaw.comHot-Stamped Patent Claim Construction2012
www.chembiotechpatentlaw.comExpansion of Standing for Walker Process Antitrust Claims2012
www.chembiotechpatentlaw.comCan the US Patent Office be Sued for Issuing Bad Patents?2012
www.chembiotechpatentlaw.comBefore the AIA: Prior Invention May Invalidate a US Patent2012
www.chembiotechpatentlaw.comA Reissue Patent Application Cannot Withdraw A Terminal Disclaimer2012
www.chembiotechpatentlaw.comU.S. Public Research Universities at Risk of Being Left in the Dust2012
School nameMajorDegreeGraduated
University of San Diego School of LawLawJD - Juris Doctor2002
University of DelawareOrganic ChemistryPhD - Doctorate1987
Glassboro State CollegeChemistryBS - Bachelor of Science1981
Speaking engagements
Conference nameTitleDate
New IP Case Law from the United StatesStrategies for Designing Around Chemical Patents2011